Clinical characterization of the mutational landscape of 24,639 real-world samples from patients with myeloid malignancies
Myeloid neoplasms are disorders of the blood arising from clonal mutations in hematopoietic stem cells and include diseases such as myelodysplastic syndromes (MDS), myeloproliferative neoplasms (MPN) and acute myeloid leukemia (AML) [1].
Source: Cancer Genetics and Cytogenetics - Category: Genetics & Stem Cells Authors: Grant Hogg, Eric Severson, Li Cai, Heidi M. Hoffmann, Kimberly A. Holden, Kerry Fitzgerald, Angela Kenyon, Qian Zeng, Michael Mooney, Sabrina Gardner, Wenjie Chen, Narasimhan Nagan, Deborah Boles, Scott Parker, Tamara J. Richman, Stanley Letovsky, Henry D Tags: Original Article Source Type: research
More News: Acute Leukemia | Acute Myeloid Leukemia | Cancer | Cancer & Oncology | Genetics | Grants | Leukemia | Myelodysplastic Syndrome | Myeloproliferative Disorders | Stem Cell Therapy | Stem Cells